References

1. Jensen J, Michaelsen M. Trochanteric femoral fractures treated with McLaughlin osteosynthesis. Acta Orthop Scand. 1975 Nov; 46(5):795-803. PubMed | Google Scholar


2. Muller ME, Nazarian S, Koch S, Koch P. Classification des fractures des os longs. Berlin Heidelberg New York: Springer- Verlag. 1990. Google Scholar


3. Manier S, Leleu X. Myélome multiple: diagnostic clinique et perspective de traitement. Recommandations de l’International Myeloma Working Group (IMWG) Immuno-analyse et biologie spécialisée. 2011; 26(3): 125-136. PubMed | Google Scholar


4. Kyle RA, Gertz MA, Witzig TE et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003 Jan; 78(1):21-33. PubMed | Google Scholar


5. Sonmez M, Akagun T, Topbas M et al. Effect of pathologic fractures on survival in multiple myeloma patients: a case control study. J Exp Clin Cancer Res. 2008 Jun 10;27:11. PubMed | Google Scholar


6. Bickels J, Dadia S, Lidar Z. Surgical management of metastatic bone disease. J Bone Joint Surg Am. 2009 Jun; 91(6):1503-16. PubMed | Google Scholar


7. Jacofsky DJ, Haidukewych GJ. Management of pathologic fractures of the proximal femur: state of the art. J Orthop Trauma. 2004 Aug;18(7):459-69. PubMed | Google Scholar


8. Field LJ, Clarke R. Detecting bony infiltrates in patients with multiple myeloma. Is there a role for computered tomography (CT) as an alternative to the radiographic skeletal survey? Radiography. 2013; 19(2):176-e182. PubMed | Google Scholar


9. Dijstra S, Wiggers T, van Geel BN, Boxma H. Impending and actual pathological fractures in patients with bone metastases of the long bones. A retrospective study of 233 surgically treated fractures. Eur J Surg. 1994 Oct; 160(10): 535-42. PubMed | Google Scholar


10. Andrea Piccioli, Barbara Rossi, Laura Scaramuzzo, Maria Silvia Spinelli, Zuozhang Yang, Giulio Maccauro. Intramedullary nailing for treatment of pathologic femoral fractures due to metastases. Injury Int J Care Injured. 2014; 45: 412417. - Google Scholar


11. Miller BJ, Soni EE, Gibbs CP, Scarborough MT. Intramedullary nails for long bone metastases: why do they fail? Orthopedics. 2011 Apr 11;34(4). PubMed | Google Scholar


12. Lahtinen R, Laakso M, Palva I et al. Randomized, placebo-controlled multicentre trial of clodronate in multiple myeloma. Lancet. 1992 Oct 31; 340(8827): 1049-52. PubMed | Google Scholar


13. Rosen LS, Gordon D, Kaminski M et al. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double blinded, comparative trial. Cancer J. 2001 Sep-Oct;7(5): 377-87. PubMed | Google Scholar


14. Kyle RA, Yee GC, Somerfield MR, Flynn PJ, Halabi S, Jagannath S et al. American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Clin Oncol. 2007 Jun 10; 25(17):2464-72. PubMed | Google Scholar